Compare TWST & GNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | GNTX |
|---|---|---|
| Founded | 2013 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.0B |
| IPO Year | 2018 | 1995 |
| Metric | TWST | GNTX |
|---|---|---|
| Price | $98.48 | $24.33 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $46.88 | $26.60 |
| AVG Volume (30 Days) | 2.1M | ★ 2.7M |
| Earning Date | 05-04-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 2.10% |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $376,572,000.00 | ★ $2,534,268,965.00 |
| Revenue This Year | $18.91 | $6.89 |
| Revenue Next Year | $15.07 | $4.58 |
| P/E Ratio | ★ N/A | $53.30 |
| Revenue Growth | ★ 20.32 | 9.55 |
| 52 Week Low | $23.30 | $20.48 |
| 52 Week High | $105.47 | $29.38 |
| Indicator | TWST | GNTX |
|---|---|---|
| Relative Strength Index (RSI) | 72.21 | 46.47 |
| Support Level | $42.88 | $22.28 |
| Resistance Level | N/A | $25.01 |
| Average True Range (ATR) | 6.09 | 0.60 |
| MACD | 1.20 | -0.18 |
| Stochastic Oscillator | 79.55 | 16.19 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.